Health

Results: 5065-5076 of 6143

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

iTeos Announces 2024 Strategic Priorities and Anticipated Milestones

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

Diamyd Medical gains market research findings to guide U.S. commercial strategy

Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock

Calliditas Therapeutics provides business update ahead of JP Morgan conference

Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis

Calliditas Therapeutics appoints Maria Törnsén as President North America

Calliditas to present at JP Morgan Healthcare Conference

Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference

PR Newswire associated0

Servier and Base4 Expand Partnership to Advance Neuroscience Drug Development